J
James Taylor
Researcher at Newcastle University
Publications - 1190
Citations - 43346
James Taylor is an academic researcher from Newcastle University. The author has contributed to research in topics: Laser & Fiber laser. The author has an hindex of 95, co-authored 1161 publications receiving 39945 citations. Previous affiliations of James Taylor include Institut national de la recherche agronomique & European Spallation Source.
Papers
More filters
Journal ArticleDOI
Broadband Raman gain characterisation in various optical fibres
TL;DR: In this paper, the Raman gain coefficient of optical fibres has been quantified using a sensitive technique based upon the measurement of backward amplified spontaneous emission, and the effect of the variation of germanium doping in the fibre is also reported.
Journal ArticleDOI
Picosecond soliton pulse-duration-selectable source based on adiabatic compression in Raman amplifier
TL;DR: In this paper, a Raman fiber amplifier was used to compress 10 ps soliton pulses generated directly from an electroabsorption modulator-based source, which were then used in a fiber-optic amplifier to achieve a pulse duration tunable source of 10 ps at 10 GHz and average power up to 650 mW.
Journal ArticleDOI
Amplification of picosecond dye laser pulses
TL;DR: In this article, a 17 cm amplifier produces a maximum small signal gain of ≈20, and with three amplifiers in series, peak pulse powers of > 3 GW are obtained.
Monitoring wheat protein content on-harvester : Australian experiences
TL;DR: An on-harvester protein sensor has been tested for two seasons on a commercial combine harvester in Australia as mentioned in this paper, and the results showed that the results were coherent and often correlated to yield response, giving a good indication that the observed protein patterns are real.
Journal ArticleDOI
The D1 receptor antagonist, SCH 23390, induces signs of parkinsonism in African green monkeys
TL;DR: Systemic administration of the selective D1 antagonist, SCH 23390, caused significant motor changes in healthy African green monkeys that suggest the possibility of parkinsonian side effects in the clinical use of this or similar D1 antagonists as treatments for psychiatric disorders.